NCT05432947
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
Clinical trial condition
Kidney Neoplasms
Explore clinical trials studying Kidney Neoplasms. Study availability and eligibility vary by location and protocol.
1,142 public trials
219 recruiting studies
Kidney Neoplasms trial results
NCT02982954
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Northwest Alabama Cancer Center, Pc Muscle Shoals, Alabama, United States
- Alaska Urological Institute dba Alaska Clinical Research Center Anchorage, Alaska, United States
- Ironwood Cancer And Research Centers, Pc Chandler, Arizona, United States
- Local Institution - 0028 Fayetteville, Arkansas, United States
NCT00142415
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- University Medical Center Nijmegen Nijmegen, Netherlands
NCT02596035
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Local Institution - 0030 Phoenix, Arizona, United States
- Comprehensive Blood And Cancer Center Bakersfield, California, United States
- St. Jude Hospital Yorba Linda Fullerton, California, United States
- Cancer Care Associates Medical Group, Inc. Redondo Beach, California, United States
Completed
Spanish Real-World Evidence Cabozantinib
NCT04510688
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Hospital Universitario Reina Sofía Córdoba, Andalusia, Spain
- Hospital Universitario Juan Ramón Jiménez Huelva, Andalusia, Spain
- Complejo Hospitalario de Jaén Jaén, Andalusia, Spain
- Hospital Son Llatzer Palma de Mallorca, Balearic Islands, Spain
NCT01975831
- Conditions
- Adenocarcinoma, Adnexal Diseases, Breast Cancer, +44 more
- Locations
-
- Yale Cancer Center New Haven, Connecticut, United States
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Roswell Park Cancer Institute Buffalo, New York, United States
- Memorial Sloan Kettering Cancer Center New York, United States
NCT02917772
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Ordensklinikum Linz Barmherzige Schwestern Linz, Austria
- AKH Wien Universitätsklinik für Innere Medizin I Vienna, Austria
- ZNA Middelheim Antwerp, Belgium
- CHR Verviers Verviers, Belgium
NCT03241173
- Conditions
- Adenocarcinoma, Adenoma, Adnexal Diseases, +74 more
- Locations
-
- The University of Alabama Birmingham (UAB) Birmingham, Alabama, United States
- Scottsdale Healthcare Hospitals DBA HonorHealth Scottsdale, Arizona, United States
- The Angeles Clinic and Research Institute Los Angeles, California, United States
- Mount Sinai Medical Center of Florida, Inc. Miami, Florida, United States
Completed
CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC)
NCT03163667
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- The University of Arizona Cancer Center Tucson, Arizona, United States
- Highlands Oncology Group Rogers, Arkansas, United States
- Los Angeles Hematology Oncology Medical Group Los Angeles, California, United States
- UCLA Department of Medicine - Hematology/Oncology Los Angeles, California, United States
NCT02348008
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
- Locations
-
- Northwestern University, Robert H. Lurie Cancer Center Chicago, Illinois, United States
- University of Illinois Cancer Center Chicago, Illinois, United States
- University of Iowa, Holden Comprehensive Cancer Center Iowa City, Iowa, United States
- University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States